AI & ChatGPT searches , social queriess for CD19
Search references for CD19. Phrases containing CD19
See searches and references containing CD19!
Search references for CD19. Phrases containing CD19
See searches and references containing CD19!CD19
Biomarker for B cell lineage
B-lymphocyte antigen CD19, also known as CD19 molecule (Cluster of Differentiation 19), B-Lymphocyte Surface Antigen B4, T-Cell Surface Antigen Leu-12
CD19
Genetically engineered T cell
dual targeting of CD19 plus CD22 or CD19 plus CD20 have demonstrated promise, and trials studying bispecific targeting to circumvent CD19 down-regulation
CAR_T_cell
Pharmaceutical drug
tumor cells. Blinatumomab is a bispecific CD19-directed CD3 T-cell engager that specifically targets the CD19 antigen present on B cells. Blinatumomab
Blinatumomab
Monoclonal antibody linked to a toxic substance
Anti-CD19 immunotoxin is a monoclonal antibody linked to a toxic substance. It is being studied in the treatment of some types of B-cell cancer. Anti-CD19
Anti-CD19_immunotoxin
Gene therapy medication
medication used for the treatment of acute lymphoblastic leukemia. It is a CD19-directed genetically modified autologous T-cell immunotherapy. The most common
Obecabtagene_autoleucel
Type of immune cell
Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C (January 2010). "CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals
Regulatory_B_cell
Blood cancer characterized by overproduction of lymphoblasts
fragment (scFv) designed to recognize the cell-surface marker CD19 as a method of treating ALL. CD19 is a molecule on all B-cells and can be used to distinguish
Acute_lymphoblastic_leukemia
Monoclonal antibody
monoclonal antibody that binds to and depletes CD19+ B cells including plasmablasts and plasma cells (a CD19-directed cytolytic antibody). The most common
Inebilizumab
American immunologist
integral to the success of CAR therapies. In 2003, Sadelain's lab identified CD19 as a target for CAR therapy in mice. Following the establishment of clinical
Michel_Sadelain
White blood cell that secretes large volumes of antibodies
surface antigens, and do not express common pan-B cell markers, such as CD19 and CD20. Instead, plasma cells are identified through flow cytometry by
Plasma_cell
Type of cytotoxic lymphocyte
NK cells derived from umbilical cord blood have been used to generate CAR.CD19 NK cells. These cells are capable of self-producing the cytokine IL-15, thereby
Natural_killer_cell
Experimental drug
humanised monoclonal antibody that binds CD19 and Fc gamma receptor IIb to inhibit B cells, plasmablasts, and CD19-expressing plasma cells." Perugino, Cory
Obexelimab
Autoimmune disease of skin and muscle
dazukibart, have demonstrated promising efficacy. Novel approaches such as CD19 chimeric antigen receptor (CAR) T-cell therapy, plasma cell–directed therapies
Dermatomyositis
Type of blood cancer
B-cells based on their expression of B-cell marker proteins (e.g. CD20, CD19, CD22, CD79, PAX5, BOB1, OCT2, an immunoglobulin [usually IgM but occasionally
Diffuse_large_B-cell_lymphoma
Australian biotechnology company
immunity. Solid tumours don't express CD19 on their cell surface, therefore introducing the CF33-CD19 allowed for CD19 to be present on the solid tumour cell
Imugene
Medication to treat large B-cell lymphoma
and neurological toxicities. Due to CD19 being a pan-B cell marker, the T-cells that are engineered to target CD19 receptors on the cancerous B cells also
Axicabtagene_ciloleucel
Artificial protein
example, AFM11 is based on the TandAbs platform and targets both CD3 and CD19 to achieve therapeutic effects. AFM11 showed dose-dependent inhibition of
Bispecific monoclonal antibody
Bispecific_monoclonal_antibody
Protein found in humans
Complement receptor 2 interacts with CD19, and, on mature B cells, forms a complex with CD81 (TAPA-1). The CR2-CD19-CD81 complex is often called the B cell
Complement_receptor_2
Immune disorder
failure in antibody production. Mutations in the genes encoding ICOS, TACI, CD19, CD20, CD21, CD80, and BAFFR have been identified as causative of CVID. Susceptibility
Common variable immunodeficiency
Common_variable_immunodeficiency
American biotechnology company
modified to express a chimeric antigen receptor designed to target the antigen CD19, a protein expressed on the cell surface of B-cell lymphomas and leukemias
Kite_Pharma
Medical therapy involving transplant of cells expanded ex vivo
CD19-targeted T cells with added DNA to stimulate cell division. As of 2015 trials had treated about 350 leukemia and lymphoma patients. Antigen CD19
Adoptive_cell_transfer
Pharmaceutical drug
designed for the treatment of CD19-positive acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma. It consists of an anti-CD19 mAb linked to monomethyl
Denintuzumab_mafodotin
Type of white blood cell
the activity of CD21, a surface receptor in complex with surface proteins CD19 and CD81 (all three are collectively known as the B cell coreceptor complex)
B_cell
Fragment
Immuntherapie CD19-positiver Leukämien und Lymphome [Development and characterisation of bispecific antibody derivatives for the immunotherapy of CD19-positive
Single-chain variable fragment
Single-chain_variable_fragment
Genetic abnormality in leukemia cancer cells
the person potentially toxic chemotherapy. Blinatumomab a CD19 monoclonal antibody (with CD19 present on B-lineage ALL cells) may be used in relapsed or
Philadelphia_chromosome
Medication
antibody-drug conjugate (ADC) composed of a humanized antibody targeting the protein CD19. The most common side effects include increased levels of gamma-glutamyltransferase
Loncastuximab_tesirine
Subtype of white blood cell
Gamma delta T cells Immunoregulation and cytotoxicity 5% (2–8%) TCRγδ and CD3 B cells Secretion of antibodies 23% (18–47%) MHC class II, CD19 and CD20
Lymphocyte
Canadian physician (born 1973)
Type 2 Diabetes Naturally". Clinical Diabetes. 37 (3): 302–303. doi:10.2337/cd19-0025. PMC 6640893. PMID 31371867. Ward, Shaun (2024). "The Diabetes Code:
Jason_Fung
Species of spider
1202875 EUNIS: 226548 Fauna Europaea: 351544 Fauna Europaea (new): 6ed96eb2-cd19-4759-b952-08cb817d1258 GBIF: 2140934 iNaturalist: 784200 IRMNG: 10895194
Agroeca_proxima
Chain reaction of white blood cell activation
induced by certain medications, such as the CD20 antibody rituximab and the CD19 CAR T cell tisagenlecleucel. The experimental drug TGN1412—also known as
Cytokine_release_syndrome
Pharmaceutical drug
of follicular lymphoma. Tafasitamab is a humanized Fc-modified cytolytic CD19 antibody. Tafasitamab may cause serious side effects including infusion related
Tafasitamab
Autoimmune disease in which the immune system attacks healthy tissue
Mougiakakos D, Böltz S, Wilhelm A, Aigner M, et al. (October 2022). "Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus". Nature Medicine
Lupus
Protein found in humans
B cells form complexes with a co-accessory activation complex containing CD19, CD81, and the fragilis/Ifitm (murine equivalents of LEU13) proteins. The
Complement_receptor_1
American biopharmaceutical company
cancer. The trials will assess combinations of MEDI4736 and one of Juno's CD19 directed chimeric antigen receptor T cell candidates. In May 2015, the company
Juno_Therapeutics
American physician-scientist
CAR T cells targeting CD19. Dr. Kochenderfer and coworkers conducted early studies that demonstrated the effectiveness of anti-CD19 CAR T cells against
James_N._Kochenderfer
Cancer of plasma cells
in cell-cell interactions and signaling (ST3GAL6, TSPAN7, VCAM1, PTPRC, CD19, CD27 and CD81), 3 of them contribute to myeloma bone disease (MBD) (DKK1
Multiple_myeloma
Gene therapy medication
back to the person. The T cells are engineered to target a protein called CD19 that is common on B cells. A chimeric T cell receptor ("CAR-T") is expressed
Tisagenlecleucel
Medical condition
with chimeric antigen receptor (CAR) T cells that recognize CD19+ B cells. This shows that CD19-targeting CAR T cells could be a new therapy for patients
Antisynthetase_syndrome
treatment-resistant CD19-positive B-cell cancers, in which patients' CD4+ and CD8+ T cells are genetically engineered to express a CD19-specific CAR. Preliminary
David_G._Maloney
Medical condition
CLL/SLL, atypical CLL/SLL, and non-CLL/SLL phenotypes. These markers are: CD5, CD19, CD20, CD23, and immunoglobulins (Ig) (either Ig light chains or complete
Monoclonal B-cell lymphocytosis
Monoclonal_B-cell_lymphocytosis
Treatment of cancer using drugs that inhibit cell division or kill cells
cell lymphoma. This anti-CD19 CAR-T cell therapy is commonly known to decrease CAR-T cells which bind to the glycoprotein CD19. By decreasing the number
Chemotherapy
Monoclonal antibody
Taplitumomab paptox Monoclonal antibody Type Whole antibody Source Mouse Target CD19 Clinical data ATC code none Identifiers CAS Number 235428-87-2 Y ChemSpider
Taplitumomab_paptox
Natural killer T cells genetically engineered to combat cancer
recruiting other effectors. Preclinical models show CAR-NK efficacy against CD19+ lymphomas and HER2+ breast cancer. Natural killer cells derive from various
CAR-NK
Medical condition
an abnormal immunophenotype (CD38+ CD56+ CD19−) mixed in with cells of a normal phenotype (CD38+ CD56− CD19+); in MGUS, on average more than 3% of the
Monoclonal gammopathy of undetermined significance
Monoclonal_gammopathy_of_undetermined_significance
Endocrine gland
of clusters of differentiation, cell surface proteins – namely CD30, with CD19, CD20 and CD22, and with the absence of CD15. Other markers may also be used
Thymus
White blood cell
marrow. Furthermore, expression levels of surface markers, such as CD38 and CD19, vary among plasma cells and are associated with functional differences.
Long-lived_plasma_cell
— February 7, 2003 Kitt Peak Spacewatch · 2.1 km MPC · JPL 276437 2003 CD19 — February 8, 2003 Socorro LINEAR · 1.4 km MPC · JPL 276438 2003 CG19 —
List of minor planets: 276001–277000
List_of_minor_planets:_276001–277000
CD3 5 CD13 4 CD4 4 CD14 4 CD5 5 CD15 4 CD6 4 CD16 4 CD7 7 CD17 5 CD8 4 CD18 5 CD9 6 CD19 7 CD10 4 CD20 6 PLEO 21 At-large 35 Total pledged delegates 161
2000 Illinois Democratic presidential primary
2000_Illinois_Democratic_presidential_primary
U.S. House district for California
district RAND California Election Returns: District Definitions California Voter Foundation map - CD19 37°36′N 120°00′W / 37.6°N 120°W / 37.6; -120
California's 19th congressional district
California's_19th_congressional_district
This receptor binds to IGHV4-34 on malignant or pathogenic B cells. Unlike CD19-targeted CAR T therapies, which eliminate many healthy B cells and suppress
CART4-34_therapy
Muscular inflammatory disease of unknown origin
including blockade of interferon-β with dazukibart. Deep B-cell depletion with CD19 chimeric antigen receptor (CAR) T-cell therapy has shown preliminary evidence
Inflammatory_myopathy
receptor to elicit a response from the T cell. Once an antigen binds to the CD19 receptor, immediate downregulation in B-cell receptor (BCR) signal expression
B10_cell
Swedish-British pharmaceutical company
these trials involved combinations of MEDI4736 and one of Juno Therapeutics' CD19 directed chimeric antigen receptor T-cell candidates. In June, the company
AstraZeneca
Cell based gene therapy
single-arm multicenter trial that evaluated brexucabtagene autoleucel, a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. Participants received
Brexucabtagene_autoleucel
Medical technology
therapy used genetically modified T cells to attack cells that expressed the CD19 protein to fight the disease. In 2013, the researchers announced that 26
Gene_therapy
B cell not yet exposed to an antigen
; Greinix, Hildegard T.; Schlenke, Peter; Steinmetz, Ivo (2021-12-07). "CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA
Naive_B_cell
Mammalian protein found in humans
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
ENTPD1
Histamine receptor
biosynthesis of interferon gamma in peripheral human blood mononuclear cells and in CD19-depleted cell subsets". Immunology Letters. 70 (2): 95–99. doi:10
Histamine_H1_receptor
CAR-T therapy
days. Rapcabtagene autoleucel is an autologous CD19-directed CAR-T cell therapy that targets the CD19 antigen expressed on B-cell malignancies. The therapy
Rapcabtagene_autoleucel
Hematological malignancy
or bone marrow. The hairy cells are larger than normal and positive for CD19, CD20, CD22, CD11c, CD25, CD103, and FMC7 antigens. (CD103, CD22, and CD11c
Hairy_cell_leukemia
Manipulation of an organism's genome
Davila ML, Riviere I, Park J, Wang X, Cowell LG, et al. (March 2013). "CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory
Genetic_engineering
Human blood group classification
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
Kell_antigen_system
Family of glycoproteins
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
CD1
Protein-coding gene in humans
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
CD79A
Mammalian protein found in humans
member 8 (IGSF8, CD316) and CD36. It forms a signal transduction complex with CD19, CD21 and Leu-13 (CD225) on the surface of the B cell. On T cells CD81 associates
CD81
128721272 rs11539209 ZDHHC12 ENSG00000160446 CD19 WEGEPPC[L/V]P DQB1*02:01 chr16 28933075 rs2904880 CD19 ENSG00000177455 LB-PI4K2B-1S SRSS[S/P]AELDRSR
Minor histocompatibility antigen
Minor_histocompatibility_antigen
Protein-coding gene in humans
Fearon DT (1997). "Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen
CD79B
Gene therapy medication
Warning for T cell Malignancies Following Treatment with BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies"
Lisocabtagene_maraleucel
Group of proteins
antibody fragments, such as anti-CD19/CD16, allow the targeting of immunotherapeutic drugs to the cancer cell. Anti-CD19/CD16 diabodies have been shown
CD16
Protein-coding gene in the species Homo sapiens
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
NKG2D
and CD3 (T lymphocytes), CD14 (Monocytes), CD16 (NK cells, granulocytes), CD19 (B lymphocytes), CD20 (B lymphocytes), and CD56 (NK cells) in humans. Lineage
Lineage_markers
Political term
AD49, AD51, AD58, AD62, AD70, AD73, AD76 0 43.9% 28.5% 13.9% 2018 12 CD13, CD19, CD32, AD4, AD7, AD20, AD21, AD27, AD51, AD61, AD64, AD69 0 32.6% 23.6% 11
Write-in_candidate
Protein found in humans
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
ADAM17
Protein which in humans is encoded by the SDC1 gene
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
Syndecan_1
Protein(s) forming a major part of an organism's immune system
IV, et al. (July 2015). "Long-Lived Plasma Cells Are Contained within the CD19−CD38hiCD138+ Subset in Human Bone Marrow". Immunity. 43 (1): 132–145. doi:10
Antibody
Belgian pharmaceutical company
co-develop MacroGenics cancer drug candidate (MGD011) which targets both CD19 and CD3 proteins in treating B-cell malignant tumours. This could net MacroGenics
Janssen_Pharmaceuticals
Type of white blood cell
CD123, CD49b(DX-5)+, CD69+, Thy-1.2+, 2B4+, CD11bdull, CD117(c-kit)−, CD24−, CD19−, CD80−, CD14−, CD23−, Ly49c−, CD122−, CD11c−, Gr-1−, NK1.1−, B220−, CD3−
Basophil
Class of artificial monoclonal antibodies
assess their therapeutic efficacy and safety. Blinatumomab links T cells with CD19 receptors found on the surface of B cells. The Food and Drug Administration
T_cell_engager
Protein found in humans
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
CD244
American physician and immunologist
humans. Her group was among the first to demonstrate impressive activity of CD19 chimeric antigen receptor (CAR T cells) therapies for childhood leukemia
Crystal_Mackall
Medical condition
sometimes IgM): common variable immunodeficiency (CVID), ICOS deficiency, CD19 deficiency, TACI (TNFRSF13B) deficiency, BAFF receptor deficiency. Normal
Humoral_immune_deficiency
Acute inflammation diseases of the optic nerve and spinal cord
disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up". Journal of the Neurological Sciences
Neuromyelitis optica spectrum disorder
Neuromyelitis_optica_spectrum_disorder
Mammalian protein found in Homo sapiens
receptor proteins, including the B cell antigen receptor (BCR), CD40, or CD19. The abbreviation Lyn is derived from Lck/Yes novel tyrosine kinase, Lck
LYN
Protein involved in multiple prion diseases
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
Major_prion_protein
Protein-coding gene in the species Homo sapiens
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
Granulocyte colony-stimulating factor receptor
Granulocyte_colony-stimulating_factor_receptor
Gene therapy medication
Warning for T cell Malignancies Following Treatment with BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies"
Idecabtagene_vicleucel
Protein found in humans
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
Death_receptor_5
1981 studio album by Derek Bailey and Jamie Muir
Bailey and Jamie Muir. The timing changes from Incus 1994 CD edition (Incus CD19) to Honest Jon's 2018 CD edition. Incus: "Carminative" – 8:48 "I Soon Learned
Dart_Drug_(album)
transplant rejection Blinatumomab Blincyto BiTE mouse CD19 Y pre-B Acute lymphoblastic leukemia (ALL) (CD19+) Blontuvetmab Blontress mab veterinary CD20 Blosozumab
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
myeloperoxidase, while B and T lymphoid lineages are indicated by the expression of CD19 and cytoplasmic CD3. The fundamental feature of MPAL involves two types of
Mixed-phenotype acute leukemia
Mixed-phenotype_acute_leukemia
national convention delegates Type Del. Type Del. Type Del. CD1 6 CD10 7 CD19 6 CD2 6 CD11 6 CD20 7 CD3 7 CD12 8 CD21 6 CD4 7 CD13 8 CD22 6 CD5 8 CD14
2020 New York Democratic presidential primary
2020_New_York_Democratic_presidential_primary
Mammalian protein found in Homo sapiens
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
Nectin-3
Mammalian protein found in Homo sapiens
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
CEACAM6
Transmembrane protein on the surface of a B cell
aforementioned tyrosine kinases, the BCR and the adaptor proteins, for instance, BLNK and CD19, as well as signaling molecules, such as PI3K, PLCy2, and VAV.
B-cell_receptor
Mammalian protein found in humans
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
CD30
Species of fish
IUCN: 199092 OBIS: 281644 Open Tree of Life: 3643569 Plazi: FCBDDEC4-E83F-CD19-6432-7984231D207D WoRMS: 281644 ZooBank: 07A5D496-97CB-484A-891B-BD8949DB6C9B
Neenchelys_daedalus
Protein found in humans
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
CD78
Protein-coding gene in the species Homo sapiens
CD4 CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33
C-C_chemokine_receptor_type_7
American physician-scientist and pediatric hematologist-oncologist
relapsed/refractory ALL and will be leading a trial using a combinatorial CD19/CD22 targeted CAR-T cell approach. In addition to her work in leukemia, she
Nirali_N._Shah
Medical condition
lymphoma from other small B-cell NHLs. B-cell-associated antigens such as CD19, CD20, CD22, and CD79a are usually expressed. In contrast to small lymphocytic
MALT_lymphoma
CD19
CD19
CD19
CD19
Girl/Female
Hindu, Indian, Traditional
Inspired Invocation
Boy/Male
Hindu
Lord Ram
Boy/Male
Hindu, Indian, Marathi, Sanskrit
Lord; Master
Surname or Lastname
English
English : variant of Semper.
Boy/Male
African, American, Arabic, Australian, Chinese, Hindu, Indian, Marathi, Swahili
Brave; Strong Hearted; Courageous; Fearless
Boy/Male
Hindu
Coral, Fierce, Strong
Boy/Male
German
Courage of a Bear
Boy/Male
Hindu
Knower of virtues, Talented, Excellent, Virtuous
Girl/Female
English American
name Letitia. Joyful;happy.
Boy/Male
British, English
Friend with a Spear
CD19
CD19
CD19
CD19
CD19